<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="brief-report" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Oncol.</journal-id>
<journal-title>Frontiers in Oncology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Oncol.</abbrev-journal-title>
<issn pub-type="epub">2234-943X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fonc.2024.1365739</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Oncology</subject>
<subj-group>
<subject>Brief Research Report</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Understanding the perceived benefits, barriers, and cues to action for lung cancer screening among Latinos: A qualitative study</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Alaniz-Cant&#xfa;</surname>
<given-names>Edgar I.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Goodwin</surname>
<given-names>Kalese</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Smith</surname>
<given-names>London</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Acosta</surname>
<given-names>Eliany</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ch&#xe1;vez-I&#xf1;iguez</surname>
<given-names>Arlette</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Evans</surname>
<given-names>Mary Jo</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2621600"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gait&#xe1;n</surname>
<given-names>Marcela</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lei</surname>
<given-names>Fang</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yousefi-Nooraie</surname>
<given-names>Reza</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1054425"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fiscella</surname>
<given-names>Kevin A.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/859183"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rivera</surname>
<given-names>M. Patricia</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cupertino</surname>
<given-names>Ana Paula</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Cartujano-Barrera</surname>
<given-names>Francisco</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/871990"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
</contrib-group>    <aff id="aff1">
<sup>1</sup>
<institution>Department of Public Health Sciences, University of Rochester Medical Center</institution>, <addr-line>Rochester, NY</addr-line>, <country>United States</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Imaging Population Health Programs, University of Rochester Medical Center</institution>, <addr-line>Rochester, NY</addr-line>, <country>United States</country>
</aff>    <aff id="aff3">
<sup>3</sup>
<institution>National Alliance for Hispanic Health</institution>, <addr-line>Washington, DC</addr-line>, <country>United States</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>School of Nursing, University of Minnesota</institution>, <addr-line>Minneapolis, MN</addr-line>, <country>United States</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Department of Family Medicine, University of Rochester Medical Center</institution>, <addr-line>Rochester, NY</addr-line>, <country>United States</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>Department of Medicine, University of Rochester Medical Center</institution>, <addr-line>Rochester, NY</addr-line>, <country>United States</country>
</aff>
<aff id="aff7">
<sup>7</sup>
<institution>Department of Surgery, University of Rochester Medical Center</institution>, <addr-line>Rochester, NY</addr-line>, <country>United States</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Giorgio Scagliotti, Department of Oncology - University of Torino, Italy</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Venkata Ajay Narendra Talabattula, Delaware State University, United States</p>
<p>Umamaheswaran Gurusamy, Nationwide Children&#x2019;s Hospital, United States</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Francisco Cartujano-Barrera, <email xlink:href="mailto:Francisco_Cartujano@URMC.Rochester.edu">Francisco_Cartujano@URMC.Rochester.edu</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>20</day>
<month>03</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>14</volume>
<elocation-id>1365739</elocation-id>
<history>
<date date-type="received">
<day>04</day>
<month>01</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>11</day>
<month>03</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Alaniz-Cant&#xfa;, Goodwin, Smith, Acosta, Ch&#xe1;vez-I&#xf1;iguez, Evans, Gait&#xe1;n, Lei, Yousefi-Nooraie, Fiscella, Rivera, Cupertino and Cartujano-Barrera</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Alaniz-Cant&#xfa;, Goodwin, Smith, Acosta, Ch&#xe1;vez-I&#xf1;iguez, Evans, Gait&#xe1;n, Lei, Yousefi-Nooraie, Fiscella, Rivera, Cupertino and Cartujano-Barrera</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Introduction</title>
<p>Rates of lung cancer screening among Latinos remain low. The purpose of the study was to understand the perceived benefits, barriers, and cues to action for lung cancer screening among Latinos.</p>
</sec>
<sec>
<title>Methods</title>
<p>Participants (N=20) were recruited using community-based recruitment strategies. Eligibility criteria included: 1) self-identified as Hispanic/Latino, 2) spoke English and/or Spanish, and 3) met the USA Preventive Services Task Force eligibility criteria for lung cancer screening. Interviews were conducted in Spanish and English, audio recorded, and transcribed verbatim. Using the health belief model, a qualitative theoretical analysis was used to analyze the interviews.</p>
</sec>
<sec>
<title>Results</title>
<p>Participants&#x2019; mean age was 58.3 years old (SD=5.8), half of the participants were female, 55% had completed high school or lower educational level, and 55% reported speaking more Spanish than English. All participants were currently smoking. Fourteen participants (70%) were unaware of lung cancer screening, and eighteen (90%) did not know they were eligible for lung cancer screening. Regarding lung cancer screening, participants reported multiple perceived benefits (e.g., smoking cessation, early detection of lung cancer, increased survivorship) and barriers (e.g., fear of outcomes, cost, lung cancer screening not being recommended by their clinician). Lastly, multiple cues to actions for lung cancer screening were identified (e.g., family as a cue to action for getting screened).</p>
</sec>
<sec>
<title>Conclusions</title>
<p>Most Latinos who were eligible for lung cancer screening were unaware of it and, when informed, they reported multiple perceived benefits, barriers, and cues to action. These factors provide concrete operational strategies to address lung cancer screening among Latinos.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Latinos</kwd>
<kwd>Hispanics</kwd>
<kwd>lung cancer</kwd>
<kwd>lung cancer screening</kwd>
<kwd>lung cancer disparities</kwd>
</kwd-group>
<counts>
<fig-count count="1"/>
<table-count count="3"/>
<equation-count count="0"/>
<ref-count count="51"/>
<page-count count="10"/>
<word-count count="4664"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Thoracic Oncology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>Despite advances in lung cancer diagnosis and treatments, lung cancer remains the leading cause of cancer-related death worldwide, with an estimated 1.8 million deaths in 2020 (<xref ref-type="bibr" rid="B1">1</xref>). Among Latinos, the largest minority group in the USA (<xref ref-type="bibr" rid="B2">2</xref>), lung cancer accounts for a lower percentage of cases among men and women (8% and 6%, respectively) compared to men and women in the general USA population (14% and 13%, respectively) (<xref ref-type="bibr" rid="B3">3</xref>). This is due, in part, to the substantially younger age composition of the Latino population compared to the general USA population (<xref ref-type="bibr" rid="B4">4</xref>). However, the survival rates are lower among Latinos compared with non-Latino whites &#x2013; making lung cancer also the leading cause of cancer-related death among Latinos (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B5">5</xref>). This is partially explained by the stage at the time of diagnosis, as 83% of Latinos are diagnosed with advanced-stage disease, which carries a 5-year survival rate of only 6% (<xref ref-type="bibr" rid="B5">5</xref>). Increasing the complexity of the disparities faced by Latinos, lung cancer incidence and mortality are not homogeneous among Latino ethnic groups (<xref ref-type="bibr" rid="B6">6</xref>). For example, lung cancer incidence and mortality are nearly doubled among Cuban and Puerto Rican men compared to Mexican men (<xref ref-type="bibr" rid="B6">6</xref>), which reflects the disparities in tobacco use and cessation faced by some ethnic groups of Latinos (<xref ref-type="bibr" rid="B7">7</xref>).</p>
<p>Lung cancer screening with low-dose computed tomography decreases lung cancer mortality by 20% due to a stage shift, resulting in more lung cancers diagnosed at an early stage (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B9">9</xref>). Despite the benefits of lung cancer screening and the strong recommendations from the USA Preventive Services Task Force and the American Cancer Society (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>), rates of lung cancer screening remain low (<xref ref-type="bibr" rid="B12">12</xref>&#x2013;<xref ref-type="bibr" rid="B14">14</xref>). A recent study using data from 20 states that adopted comprehensive lung cancer screening programs reported an uptake rate of 20.7% (<xref ref-type="bibr" rid="B14">14</xref>), less than half the rate for other types of cancer screening (<xref ref-type="bibr" rid="B15">15</xref>). Moreover, marked disparities in the rate of lung cancer screening based on race, ethnicity, socioeconomic status, and geographic location have been reported (<xref ref-type="bibr" rid="B16">16</xref>&#x2013;<xref ref-type="bibr" rid="B20">20</xref>). For example, lung cancer screening uptake among Latinos remains minimal (<xref ref-type="bibr" rid="B21">21</xref>). The purpose of this study was to understand the perceived benefits, barriers, and cues to action for lung cancer screening among Latinos. The information gathered from this qualitative study will inform future interventions to increase the uptake of lung cancer screening among Latinos.</p>
</sec>
<sec id="s2">
<label>2</label>
<title>Methods</title>
<sec id="s2_1">
<label>2.1</label>
<title>Study design</title>
<p>This qualitative study consisted of semi-structured interviews in English and Spanish with Latinos to understand the perceived benefits, barriers, and cues to action for lung cancer screening. Study procedures were approved and monitored by the University of Rochester Medical Center Institutional Review Board (protocol number STUDY00007787). Participants were compensated with a $30 gift card for their time and effort.</p>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Positionality</title>
<p>In qualitative studies, the researcher is considered a research instrument given their ability to observe details, conduct in-depth interviews, and reflect on the meaning of interview data (<xref ref-type="bibr" rid="B22">22</xref>). The first author, who conducted the semi-structured interviews, is a Latino medical student interested in promoting Latino health. The second and third authors, who conducted the qualitative theoretical analysis, are medical students also interested in promoting Latino health. The last author, who supervised the qualitative theoretical analysis, is a Latino researcher trained in community-based participatory research (including qualitative studies) to address disparities among Latinos (<xref ref-type="bibr" rid="B23">23</xref>&#x2013;<xref ref-type="bibr" rid="B28">28</xref>).</p>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>Theoretical model</title>
<p>This study used the health belief model (HBM) as a theoretical model. The HBM posits that individuals act to change their health behaviors (e.g., getting screened for lung cancer) based on their perceived benefits, barriers, and cues to action (<xref ref-type="bibr" rid="B29">29</xref>). Perceived benefits refer to an individual&#x2019;s opinion of the value or usefulness of a new behavior in lowering the risk of a disease and/or condition (<xref ref-type="bibr" rid="B29">29</xref>). Perceived barriers refer to an individual&#x2019;s view of the obstacles to behavior change (<xref ref-type="bibr" rid="B29">29</xref>). Cues to action refer to events, people, or things that trigger people to change behavior (<xref ref-type="bibr" rid="B29">29</xref>).</p>
</sec>
<sec id="s2_4">
<label>2.4</label>
<title>Recruitment</title>
<p>Recruitment was conducted by a team of culturally diverse, bilingual (English and Spanish) trained recruiters between January and April 2023. Recruitment strategies included study presentations in venues with a high concentration of Latinos (e.g., community-based organizations, festivals, malls), referrals from the Wilmot Tobacco Cessation Center at the University of Rochester Medical Center, and word of mouth from community partners.</p>
</sec>
<sec id="s2_5">
<label>2.5</label>
<title>Eligibility</title>
<p>Individuals were eligible if they (1) self-identify as Hispanic/Latino; (2) speak English and/or Spanish; (3) were between 50 and 80 years old; (4) had not completed their annual screening for lung cancer with LDCT; (5) had a 20 pack-year smoking history; (6) currently smoked cigarettes or had quit within the past 15 years; (7) were interested in participating in a 90-minute interview; and (8) were comfortable with communicating over Zoom<sup>&#xae;</sup> or a phone call for the interview. Eligibility criteria 3, 4, 5, and 6 were consistent with the 2021 USA Preventive Services Task Force eligibility for lung cancer screening (<xref ref-type="bibr" rid="B10">10</xref>). Study staff conducted an eligibility assessment over the phone in the participant&#x2019;s language of preference, either English or Spanish.</p>
</sec>
<sec id="s2_6">
<label>2.6</label>
<title>Consent</title>
<p>Individuals eligible to participate in the study received an informational letter with detailed information about the study (e.g., procedures, confidentiality, contact information of the study team). The informational letter was available in English and Spanish. The first author reviewed the informative letter with participants. Verbal consent was obtained from the participants before enrollment in the study.</p>
</sec>
<sec id="s2_7">
<label>2.7</label>
<title>Data collection</title>
<p>Before the interview, the first author conducted a sociodemographic survey to collect information on age, gender, sexual orientation, education level, language of preference, and country of birth. Moreover, smoking-related variables were collected, including current smoking status, number of cigarettes smoked per day (CPD), age that the participant started smoking, time to their first cigarette, use of menthol cigarettes, quit attempt in the past year, and ever use of pharmacotherapy and electronic cigarettes for cessation. Lastly, participants were asked if they were aware of lung cancer screening (i.e., Before this study, have you ever heard about lung cancer screening with low-dose CT scan? Yes/No) and if they knew they were eligible (i.e., Before this study, did you know you were eligible to screen for lung cancer with low-dose CT scan? Yes/No). The survey was completed in the participants&#x2019; language of preference, either English or Spanish.</p>
<p>Immediately after the sociodemographic survey, the first author conducted a semi-structured interview. An interview guide with open-ended questions was used to facilitate the interviews. The interview was completed in the participants&#x2019; language of preference, either English or Spanish. The HBM was used to develop the interview guide (<xref ref-type="bibr" rid="B30">30</xref>). <xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref> shows examples of the interview questions by the HBM factor.</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Examples of interview questions using the Health Belief Model.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Factor</th>
<th valign="top" align="left">Interview Questions</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Perceived benefits</td>
<td valign="top" align="left">What benefits do you think an individual can get from screening for lung cancer?</td>
</tr>
<tr>
<td valign="top" align="left">Perceived barriers</td>
<td valign="top" align="left">What do you think may prevent an individual from screening for lung cancer?</td>
</tr>
<tr>
<td valign="top" align="left">Cues to action</td>
<td valign="top" align="left">What could trigger a person to decide to screen for lung cancer?</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>The first author conducted the interviews. All interviews were audio-taped and subsequently transcribed verbatim in the language they were conducted. Interviews in Spanish were translated to English. The interviewer verified the translations and resolved any discrepancies using a consensus approach (<xref ref-type="bibr" rid="B31">31</xref>).</p>
</sec>
<sec id="s2_8">
<label>2.8</label>
<title>Analyses</title>
<p>For the sociodemographic and smoking-related questions, means and frequencies were calculated. Interview data were analyzed manually after all data were collected. Qualitative theoretical analysis was used to identify, analyze, and report themes within the interview data (<xref ref-type="bibr" rid="B32">32</xref>). The second and third authors independently coded the first five transcripts through line-by-line coding. An iterative process was employed to achieve consensus between the two sets of codes, create a coding scheme, and develop a codebook that included details about agreed-upon code definitions. New codes were added to the coding scheme as needed until no new themes emerged with successive interviews (<xref ref-type="bibr" rid="B33">33</xref>). The last author supervised the qualitative theoretical analysis and provided in-depth feedback on the codebook development. All authors agreed on the final themes and sub-themes.</p>
</sec>
<sec id="s2_9">
<label>2.9</label>
<title>Sample size</title>
<p>Based on principles of data saturation, the study estimated a sample size of twenty participants to collect enough data to draw necessary conclusions (<xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B35">35</xref>).</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="s3_1">
<label>3.1</label>
<title>Baseline characteristics</title>
<p>As shown in <xref ref-type="table" rid="T2">
<bold>Table&#xa0;2</bold>
</xref>, the participants&#x2019; mean age was 58.3 years old (SD 5.84), 50% of the participants were female, 85% self-identified as heterosexual or straight, 55% had an education of high school or less, and 55% indicated &#x201c;more Spanish than English&#x201d; as their language of preference. Twelve participants (60%) were born in Puerto Rico. All participants (100%) were currently smoking, 55% smoked 1-10 cigarettes daily, 20% smoked their first cigarette within five minutes after waking up, and 70% used menthol cigarettes. Twelve participants (60%) had made a quit attempt in the past year, and 90% had used pharmacotherapy for cessation. Fourteen participants (70%) were unaware of lung cancer screening and 90% were unaware they were eligible for lung cancer screening. Half of the participants (50%) were insured by Medicaid. <xref ref-type="table" rid="T3">
<bold>Table&#xa0;3</bold>
</xref> describes each participant&#x2019;s age, gender, and language of preference.</p>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>Characteristics of participants (n=20).</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="left">Characteristics</th>
<th valign="middle" align="left">n = 20 (%)</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="left">Age, Mean (SD)</td>
<td valign="middle" align="center">58.3 (5.84)</td>
</tr>
<tr>
<th valign="middle" colspan="2" align="left">Gender</th>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Female</td>
<td valign="middle" align="center">10 (50.0%)</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Male</td>
<td valign="middle" align="center">9 (45.0%)</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Transgender Male</td>
<td valign="middle" align="center">1 (5.0%)</td>
</tr>
<tr>
<th valign="middle" colspan="2" align="left">Sexual orientation</th>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Heterosexual or straight</td>
<td valign="middle" align="center">17 (85.0%)</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Homosexual or gay</td>
<td valign="middle" align="center">1 (5.0%)</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Bisexual</td>
<td valign="middle" align="center">2 (10.0%)</td>
</tr>
<tr>
<th valign="middle" colspan="2" align="left">Education level</th>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;High school or less</td>
<td valign="middle" align="center">11 (55.0%)</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;More than high school</td>
<td valign="middle" align="center">9 (45.0%)</td>
</tr>
<tr>
<th valign="middle" colspan="2" align="left">Language of preference</th>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Only Spanish</td>
<td valign="middle" align="center">3 (15.0%)</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;More Spanish than English</td>
<td valign="middle" align="center">11 (55.0%)</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Both equally</td>
<td valign="middle" align="center">3 (15.0%)</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;More English than Spanish</td>
<td valign="middle" align="center">3 (15.0%)</td>
</tr>
<tr>
<th valign="middle" colspan="2" align="left">Country of birth</th>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Puerto Rico</td>
<td valign="middle" align="center">12 (60.0%)</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;USA</td>
<td valign="middle" align="center">5 (25.0%)</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Cuba</td>
<td valign="middle" align="center">2 (10.0%)</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Dominican Republic</td>
<td valign="middle" align="center">1 (5.0%)</td>
</tr>
<tr>
<td valign="middle" align="left">Currently smoking</td>
<td valign="middle" align="center">20 (100%)</td>
</tr>
<tr>
<th valign="middle" colspan="2" align="left">Smoking pattern</th>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Daily, 1&#x2013;10 CPD</td>
<td valign="middle" align="center">11 (55.0%)</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Daily, 11&#x2013;20 CPD</td>
<td valign="middle" align="center">9 (45.0%)</td>
</tr>
<tr>
<td valign="middle" align="left">Age that participant started smoking, Mean (SD)</td>
<td valign="middle" align="center">17.1 (3.73)</td>
</tr>
<tr>
<th valign="middle" colspan="2" align="left">Time to first cigarette</th>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;&#x2264; 5 minutes after waking up</td>
<td valign="middle" align="center">4 (20.0%)</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;&gt; 5 minutes after waking up</td>
<td valign="middle" align="center">16 (80.0%)</td>
</tr>
<tr>
<td valign="middle" align="left">Use of menthol cigarettes</td>
<td valign="middle" align="center">13 (70.0%)</td>
</tr>
<tr>
<th valign="middle" colspan="2" align="left">Quit attempt in the past year</th>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Yes</td>
<td valign="middle" align="center">12 (60.0%)</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;No</td>
<td valign="middle" align="center">8 (40.0%)</td>
</tr>
<tr>
<td valign="middle" align="left">Use of pharmacotherapy for cessation in the past <sup>1</sup>
</td>
<td valign="middle" align="center">18 (90.0%)</td>
</tr>
<tr>
<td valign="middle" align="left">Use of e-cigarettes for cessation in the past</td>
<td valign="middle" align="center">7 (35.0%)</td>
</tr>
<tr>
<td valign="middle" align="left">Unaware of lung cancer screening</td>
<td valign="middle" align="center">14 (70.0%)</td>
</tr>
<tr>
<td valign="middle" align="left">Unaware they were eligible for lung cancer screening</td>
<td valign="middle" align="center">18 (90.0%)</td>
</tr>
<tr>
<th valign="middle" colspan="2" align="left">Type of health insurance <sup>2</sup>
</th>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Medicaid</td>
<td valign="middle" align="center">10 (50%)</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Medicare</td>
<td valign="middle" align="center">7 (35%)</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Private</td>
<td valign="middle" align="center">9 (45%)</td>
</tr>
<tr>
<td valign="middle" align="left">&#x2003;Employee</td>
<td valign="middle" align="center">2 (10%)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>SD, Standard deviation; CPD, Cigarettes per day <sup>1</sup>. Pharmacotherapy for cessation included the nicotine patch, nicotine gum, nicotine lozenge, nicotine nasal spray, nicotine inhaler, Chantix<sup>&#xae;</sup>/Varenicline, and Zyban<sup>&#xae;</sup>/Bupropion <sup>2</sup>. Participants could have more than one insurance plan.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="T3" position="float">
<label>Table&#xa0;3</label>
<caption>
<p>Participants&#x2019; age, gender, and language of preference.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="left">Participant</th>
<th valign="middle" align="left">Age</th>
<th valign="middle" align="left">Gender</th>
<th valign="middle" align="left">Language of Preference</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="left">Participant 1</td>
<td valign="middle" align="left">61</td>
<td valign="middle" align="left">Male</td>
<td valign="middle" align="left">More English than Spanish</td>
</tr>
<tr>
<td valign="middle" align="left">Participant 2</td>
<td valign="middle" align="left">65</td>
<td valign="middle" align="left">Female</td>
<td valign="middle" align="left">English and Spanish equally</td>
</tr>
<tr>
<td valign="middle" align="left">Participant 3</td>
<td valign="middle" align="left">50</td>
<td valign="middle" align="left">Transgender male</td>
<td valign="middle" align="left">More Spanish than English</td>
</tr>
<tr>
<td valign="middle" align="left">Participant 4</td>
<td valign="middle" align="left">61</td>
<td valign="middle" align="left">Female</td>
<td valign="middle" align="left">More Spanish than English</td>
</tr>
<tr>
<td valign="middle" align="left">Participant 5</td>
<td valign="middle" align="left">63</td>
<td valign="middle" align="left">Male</td>
<td valign="middle" align="left">More English than Spanish</td>
</tr>
<tr>
<td valign="middle" align="left">Participant 6</td>
<td valign="middle" align="left">51</td>
<td valign="middle" align="left">Female</td>
<td valign="middle" align="left">Only Spanish</td>
</tr>
<tr>
<td valign="middle" align="left">Participant 7</td>
<td valign="middle" align="left">74</td>
<td valign="middle" align="left">Female</td>
<td valign="middle" align="left">More Spanish than English</td>
</tr>
<tr>
<td valign="middle" align="left">Participant 8</td>
<td valign="middle" align="left">59</td>
<td valign="middle" align="left">Female</td>
<td valign="middle" align="left">Only Spanish</td>
</tr>
<tr>
<td valign="middle" align="left">Participant 9</td>
<td valign="middle" align="left">61</td>
<td valign="middle" align="left">Male</td>
<td valign="middle" align="left">More Spanish than English</td>
</tr>
<tr>
<td valign="middle" align="left">Participant 10</td>
<td valign="middle" align="left">62</td>
<td valign="middle" align="left">Male</td>
<td valign="middle" align="left">More Spanish than English</td>
</tr>
<tr>
<td valign="middle" align="left">Participant 11</td>
<td valign="middle" align="left">58</td>
<td valign="middle" align="left">Male</td>
<td valign="middle" align="left">More Spanish than English</td>
</tr>
<tr>
<td valign="middle" align="left">Participant 12</td>
<td valign="middle" align="left">61</td>
<td valign="middle" align="left">Male</td>
<td valign="middle" align="left">More Spanish than English</td>
</tr>
<tr>
<td valign="middle" align="left">Participant 13</td>
<td valign="middle" align="left">60</td>
<td valign="middle" align="left">Female</td>
<td valign="middle" align="left">More Spanish than English</td>
</tr>
<tr>
<td valign="middle" align="left">Participant 14</td>
<td valign="middle" align="left">52</td>
<td valign="middle" align="left">Female</td>
<td valign="middle" align="left">More Spanish than English</td>
</tr>
<tr>
<td valign="middle" align="left">Participant 15</td>
<td valign="middle" align="left">55</td>
<td valign="middle" align="left">Male</td>
<td valign="middle" align="left">More English than Spanish</td>
</tr>
<tr>
<td valign="middle" align="left">Participant 16</td>
<td valign="middle" align="left">57</td>
<td valign="middle" align="left">Female</td>
<td valign="middle" align="left">English and Spanish equally</td>
</tr>
<tr>
<td valign="middle" align="left">Participant 17</td>
<td valign="middle" align="left">56</td>
<td valign="middle" align="left">Male</td>
<td valign="middle" align="left">English and Spanish equally</td>
</tr>
<tr>
<td valign="middle" align="left">Participant 18</td>
<td valign="middle" align="left">52</td>
<td valign="middle" align="left">Male</td>
<td valign="middle" align="left">More Spanish than English</td>
</tr>
<tr>
<td valign="middle" align="left">Participant 19</td>
<td valign="middle" align="left">50</td>
<td valign="middle" align="left">Female</td>
<td valign="middle" align="left">Only Spanish</td>
</tr>
<tr>
<td valign="middle" align="left">Participant 20</td>
<td valign="middle" align="left">58</td>
<td valign="middle" align="left">Female</td>
<td valign="middle" align="left">More Spanish than English</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>Perceived benefits</title>
<p>As shown in <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>, participants identified five benefits of lung cancer screening: 1) Smoking cessation, 2) early detection of lung cancer, 3) increased survivorship, 4) self-care, and 5) peace of mind. Select quotes from participants are shown below.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Perceived benefits, barriers, and cues to action for lung cancer screening among Latinos.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fonc-14-1365739-g001.tif"/>
</fig>
<sec id="s3_2_1">
<label>3.2.1</label>
<title>Smoking cessation</title>
<p>Fifteen participants described that lung cancer screening would be beneficial for smoking cessation:</p>
<disp-quote>
<p>&#x201c;It [getting screened for lung cancer] would benefit me by quitting smoking &#x2026; I would stop, I would stop &#x2026; It would be good because then I could try to quit smoking &#x2026; The first thing that comes to mind is to completely quit smoking. And see how I would survive.&#x201d; Participant 3</p>
<p>&#x201c;Well, the benefit [of lung cancer screening] would be to know that you have a condition in your lungs and that you need to treat it &#x2026; and do everything possible to turn it into a positive thing in your life, like quitting smoking&#x201d;. Participant 10</p>
<p>&#x201c;It [lung cancer screening] might also help me quit smoking &#x2026; Well, maybe if I&#x2019;m already sick, it would make me think and quit smoking &#x2026; I&#x2019;d do everything possible to quit smoking.&#x201d; Participant 19</p>
</disp-quote>
</sec>
<sec id="s3_2_2">
<label>3.2.2</label>
<title>Early detection of lung cancer</title>
<p>Thirteen participants described that lung cancer screening would be beneficial for early detection of lung cancer:</p>
<disp-quote>
<p>&#x201c;I think that early detection on anything that can be fatal is great &#x2026; So, it [lung cancer screening] is saving lives because of detecting it [lung cancer] early&#x2026;.&#x201d; Participant 2</p>
<p>&#x201c;&#x2026;If it [the lung cancer] is not advanced, you have a solution &#x2026; like to remove it so that it does not continue to affect the body&#x201d;. Participant 5</p>
<p>&#x201c;[A benefit would be] getting the results before it&#x2019;s full-blown cancer&#x201d;. Participant 13</p>
</disp-quote>
</sec>
<sec id="s3_2_3">
<label>3.2.3</label>
<title>Increased survivorship</title>
<p>Nine participants described that lung cancer screening would be beneficial for increasing their survival rate:</p>
<disp-quote>
<p>&#x201c;If I find something wrong &#x2026; I would benefit because I would be in time to know &#x2026; The person would be in time to make decisions or to do a treatment to save his life&#x2026;&#x201d; Participant 3</p>
<p>&#x201c;If you get screened [for lung cancer] early, there&#x2019;s a higher chance of living longer&#x201d;. Participant 11</p>
<p>&#x201c;There are solutions, there are things that are good, that extend life &#x2026; Whether it be [lung] cancer or whatever &#x2026; the [cancer] treatment lengthens your life&#x201d;. Participant 18</p>
</disp-quote>
</sec>
<sec id="s3_2_4">
<label>3.2.4</label>
<title>Self-care</title>
<p>Four participants described that lung cancer screening would be beneficial for self-care:</p>
<disp-quote>
<p>&#x201c;I would take care of myself &#x2026; As I told you, be more careful, prevent my lung from getting damaged completely&#x2026;&#x201d;. Participant 7</p>
</disp-quote>
</sec>
<sec id="s3_2_5">
<label>3.2.5</label>
<title>Peace of mind</title>
<p>Three participants described that lung cancer screening would be beneficial for their peace of mind:</p>
<disp-quote>
<p>&#x201c;[I would get screened for lung cancer] to get rid of the worry &#x2026; The worry of having something&#x2026;&#x201d; Participant 10</p>
</disp-quote>
</sec>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title>Perceived barriers</title>
<p>As shown in <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>, participants identified seven barriers to lung cancer screening: 1) Fear of outcomes, 2) cost, 3) lung cancer screening not being recommended by their clinician, 4) lack of knowledge about the procedure, 5) self-blame, 6) transportation, and 7) lack of time. Select quotes from participants are shown below.</p>
<sec id="s3_3_1">
<label>3.3.1</label>
<title>Fear of outcomes</title>
<p>Seventeen participants described fear of outcomes as a barrier to lung cancer screening:</p>
<disp-quote>
<p>&#x201c;Not having the desire to do it [getting screened for lung cancer] because of fear &#x2026; Fear of being told, &#x2018;Look, the test came back positive, and you have lung cancer. You need treatment, etc.&#x2019; Latinos are like that &#x2026; We don&#x2019;t want to face reality sometimes.&#x201d; Participant 8</p>
<p>&#x201c;I&#x2019;m worried because I smoke, and I have a chance of getting lung cancer.&#x201d; Participant 11</p>
<p>&#x201c;Fear &#x2026; That it [being diagnosed with lung cancer] could happen to me &#x2026; To leave my son! I hear that word &#x2018;cancer&#x2019; and it scares me. Fear that I have a disease&#x2026;&#x201d; Participant 20</p>
</disp-quote>
</sec>
<sec id="s3_3_2">
<label>3.3.2</label>
<title>Cost</title>
<p>Ten participants described cost as a barrier to lung cancer screening:</p>
<disp-quote>
<p>&#x201c;I know that financially, I don&#x2019;t have the money. Because I do believe the test [lung cancer screening] is expensive &#x2026; They [healthcare professionals] never told me how much it costs &#x2026; I don&#x2019;t know &#x2026; The test is expensive, and no plan covers it&#x201d;. Participant 7</p>
<p>&#x201c;Because there are many people who their [insurance] plan does not cover them [lung cancer screening] &#x2026; Or they do not have a medical plan, because then it is the lack of money.&#x201d; Participant 4</p>
<p>&#x201c;Some people don&#x2019;t have the resources to get it [lung cancer screening] done because you know they charge you for everything here [at the medical center].&#x201d; Participant 12</p>
</disp-quote>
</sec>
<sec id="s3_3_3">
<label>3.3.3</label>
<title>Lung cancer screening is not being recommended by their clinician</title>
<p>Eight participants described lung cancer screening not recommended by their clinician as a barrier to lung cancer screening:</p>
<disp-quote>
<p>&#x201c;Because no one, not even my doctor, ever mentioned getting a cancer screening test.&#x201d; Participant 11</p>
<p>&#x201c;To tell you the truth, they [healthcare professionals] have never recommended it [lung cancer screening] to me. I didn&#x2019;t know, I found out because you called me&#x2026;&#x201d; Participants 18</p>
</disp-quote>
</sec>
<sec id="s3_3_4">
<label>3.3.4</label>
<title>Lack of knowledge about the procedure</title>
<p>Ten participants described lack of knowledge about the procedure as a barrier to lung cancer screening:</p>
<disp-quote>
<p>&#x201c;I&#x2019;m going to be honest, I thought that the plates, X-rays, were enough. I thought that if I did the plates and no stain came out, it would be like there was nothing. I didn&#x2019;t know there was another more detailed test. What is the test about? What can it prevent? Early detection? That it can save your life? Things like that &#x2026; How to do it and where to?&#x201d; Participant 9</p>
<p>&#x201c;I&#x2019;d like to know if it [lung cancer screening] is painful &#x2026; What happens during the test and if it&#x2019;s uncomfortable &#x2026; I don&#x2019;t know anything, I&#x2019;m totally blank.&#x201d; Participant 19</p>
</disp-quote>
</sec>
<sec id="s3_3_5">
<label>3.3.5</label>
<title>Self-blame</title>
<p>Three participants described self-blame as a barrier to lung cancer screening:</p>
<disp-quote>
<p>&#x201c;I mean just to know that the old bad habit [cigarette smoking], or actually my bad habit, caused me to have lung cancer &#x2026; So, I did it to myself &#x2026; Because nobody forced you to smoke. You do it on your own. On your own free will &#x2026; Despite people telling you to quit smoking &#x2026; Umm, it will have a terrible impact and I will blame myself.&#x201d; Participant 13</p>
</disp-quote>
</sec>
<sec id="s3_3_6">
<label>3.3.6</label>
<title>Transportation</title>
<p>Three participants described transportation as a barrier to lung cancer screening:</p>
<disp-quote>
<p>&#x201c;Transportation is the most difficult [barrier] &#x2026; Transportation &#x2026; I don&#x2019;t have a car&#x201d; Participant 3</p>
</disp-quote>
</sec>
<sec id="s3_3_7">
<label>3.3.7</label>
<title>Lack of time</title>
<p>Two participants described lack of time as a barrier to lung cancer screening:</p>
<disp-quote>
<p>&#x201c;The lack of time &#x2026; because there are many people who have two jobs, three jobs to be able to support themselves, and if they miss a day [to get screened for lung cancer] the budget is out of balance&#x2026;&#x201d; Participant 4</p>
</disp-quote>
</sec>
</sec>
<sec id="s3_4">
<label>3.4</label>
<title>Cues to action</title>
<p>As shown in <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>, participants identified four cues to action for lung cancer screening: 1) Family, 2) recommendation by healthcare professionals, 3) printed and online educational materials, and 4) having symptoms. Select quotes from participants are shown below.</p>
<sec id="s3_4_1">
<label>3.4.1</label>
<title>Family</title>
<p>Twelve participants described family as a cue to action for lung cancer screening:</p>
<disp-quote>
<p>&#x201c;Family is just like your own heart, man&#x2026;. You can do anything as much as anybody can, you can motivate yourself [to get screened for lung cancer] just by looking at your son&#x201d;. Participant 1</p>
<p>&#x201c;My kids are always telling me to check my lungs. Because they&#x2019;re always worried about how your lungs are when they see you cough or when they see you smoke. And because they care. Because they are afraid that I will leave [die] early as they say.&#x201d; Participant 3</p>
<p>&#x201c;I said to myself. Well, I want to live long enough to see my grandkids. That&#x2019;s why I would do it [get screened for lung cancer] now!&#x201d; Participant 13</p>
</disp-quote>
</sec>
<sec id="s3_4_2">
<label>3.4.2</label>
<title>Recommendation by healthcare professionals</title>
<p>Fourteen participants described recommendation by healthcare professionals as a cue to action for lung cancer screening:</p>
<disp-quote>
<p>&#x201c;If the doctor orders it [lung cancer screening], then I&#x2019;ll get it done.&#x201d; Participant 10</p>
<p>&#x201c;Okay, if I do it, I would like my doctor to tell me &#x2018;[Participants name] you have to stop by the [lung cancer screening] office, you have to be there&#x2026;&#x201d; Participant 18</p>
</disp-quote>
</sec>
<sec id="s3_4_3">
<label>3.4.3</label>
<title>Printed and online educational materials</title>
<p>Fifteen participants described printed and online educational materials as a cue to action for lung cancer screening:</p>
<disp-quote>
<p>&#x201c;Advertise the lung cancer screening program and then explain what lung cancer screening is&#x2026;.More information &#x2026; [On a] webpage &#x2026; Platforms &#x2026; Social media&#x2026;. Regular flyers&#x2026;&#x201d; Participant 1</p>
<p>&#x201c;Have brochures in the, in the, in medical offices. In the medical buildings, in those main [medical] centers &#x2026; For them to have information brochures, such as: &#x201c;Get tested.&#x201d; So that they explain how it is done, where it can be done, how it has to be done, that is good because people take it, and it is prevention.&#x201d; Participant 4</p>
</disp-quote>
</sec>
<sec id="s3_4_4">
<label>3.4.4</label>
<title>Symptoms</title>
<p>Ten participants described that having symptoms was a cue to action for lung cancer screening:</p>
<disp-quote>
<p>&#x201c;[What could trigger a person to decide to screen for lung cancer is] the deterioration of health, the start of a period with a lot of coughing &#x2026; Lack of oxygen&#x2026;&#x201d; Participant 9</p>
<p>&#x201c;They [healthcare professionals] recommended that I get the lung test done because I have trouble breathing.&#x201d; Participant 11</p>
</disp-quote>
</sec>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p>To the best of our knowledge, this is the first qualitative study to understand the perceived benefits, barriers, and cues to action for lung cancer screening among Latinos living in the USA In this study, most Latinos were unaware of lung cancer screening (70%) and that they were eligible for screening (90%). When informed, participants identified multiple perceived benefits (e.g., smoking cessation, early detection of lung cancer), barriers (e.g., fear of outcomes, cost), and cues to action (e.g., family, recommendation by healthcare professionals) to lung cancer screening.</p>
<p>Percac-Lima et&#xa0;al. conducted a cross-sectional survey to assess barriers to and interest in lung cancer screening among 118 Latino and 342 non-Latino individuals (<xref ref-type="bibr" rid="B36">36</xref>). Importantly, less than half of Latinos (44.1%) were unaware of lung cancer screening (<xref ref-type="bibr" rid="B36">36</xref>). Moreover, findings from our study expand this work by understanding the perceived benefits and cues to action for lung cancer screening among Latinos. Nevertheless, the results of this study confirm two previously described barriers: Cost and lack of knowledge about lung cancer screening. Rodr&#xed;guez-Rabassa et&#xa0;al. conducted focus groups with 37 individuals living in Puerto Rico to understand their perceptions of and barriers to lung cancer screening (<xref ref-type="bibr" rid="B37">37</xref>). Moreover, findings of this study support three previously identified barriers: 1) lack of knowledge about lung cancer screening, 2) perceived financial barriers to getting screened, and 3) fear of outcomes. In addition, our study emphasizes that if healthcare professionals recommend lung cancer screening, most Latinos would partake in the screening.</p>
<p>Some of the perceived barriers to lung cancer screening characterize the social determinants of health (SDOH). The SDOH are factors outside of the realm of medicine that impact health outcomes (<xref ref-type="bibr" rid="B38">38</xref>, <xref ref-type="bibr" rid="B39">39</xref>). The SDOH include five interconnected domains: economic stability, education, neighborhood, built environment, social and community context, and access to care and health care quality (<xref ref-type="bibr" rid="B38">38</xref>, <xref ref-type="bibr" rid="B39">39</xref>). Cost and transportation as perceived barriers to lung cancer screening are part of economic stability. Moreover, lung cancer screening not being recommended by clinicians is part of health care quality. Addressing the SDOH is imperative to make progress toward health equity, a state in which every person can attain their highest level of health (<xref ref-type="bibr" rid="B40">40</xref>).</p>
<p>Participants identified smoking cessation as a benefit of lung cancer screening. Integrating evidence-based smoking cessation treatment into lung cancer screening programs maximizes the impact of lung cancer screening (<xref ref-type="bibr" rid="B41">41</xref>, <xref ref-type="bibr" rid="B42">42</xref>). Taylor et&#xa0;al. conducted a randomized controlled trial (RCT) with 818 patients receiving lung cancer screening in eight USA screening sites (<xref ref-type="bibr" rid="B43">43</xref>). Results of the RCT showed that delivering intensive telephone counseling and nicotine replacement therapy with lung cancer screening is an effective strategy to increase smoking cessation at month 3 (<xref ref-type="bibr" rid="B43">43</xref>). Moreover, in a cost-effectiveness analysis of the intervention, telephone counseling and nicotine replacement therapy were considered cost-effective in lung cancer screening settings (<xref ref-type="bibr" rid="B44">44</xref>). Integrating smoking cessation interventions with lung screening programs has the potential to maximize long-term health benefits at reasonable costs.</p>
<p>Participants identified family as a cue to action for lung cancer screening (e.g., getting screened so they can be there for their family for years to come). This result is consistent with the cultural value of <italic>familismo</italic> among Latinos (<xref ref-type="bibr" rid="B45">45</xref>, <xref ref-type="bibr" rid="B46">46</xref>). <italic>Familismo</italic> (familism) refers to the tendency to place a high value on the central position that the family holds in the life of the individual and to view decisions by the individual in the context of the well-being of the family (<xref ref-type="bibr" rid="B45">45</xref>, <xref ref-type="bibr" rid="B46">46</xref>). Direct encouragement among family members has been shown to influence cancer screening (e.g., breast, cervical, and colorectal cancer screening) among Latinos (<xref ref-type="bibr" rid="B47">47</xref>&#x2013;<xref ref-type="bibr" rid="B50">50</xref>). Future interventions that aim to increase the uptake of lung cancer screening among Latinos should consider this identified cue to action.</p>
<sec id="s4_1">
<label>4.1</label>
<title>Strengths and limitations</title>
<p>Our study had multiple strengths. First, this research builds upon an established history of smoking cessation research with the Latino community (<xref ref-type="bibr" rid="B23">23</xref>&#x2013;<xref ref-type="bibr" rid="B28">28</xref>). Second, this work is grounded in principles of community-based participatory research (CPBR). CBPR is a partnership approach to research that involves community members, organizational representatives, and researchers across all phases of research (<xref ref-type="bibr" rid="B51">51</xref>). This approach ensures that the research is relevant, meaningful, and appropriate to the population for which it is planned. Third, this study benefited from an adequate sample size that gave us sufficient information to understand the perspectives of Latinos on lung cancer screening (<xref ref-type="bibr" rid="B35">35</xref>). Fourth, the use of the HBM framework is another strength. This model provided a conceptual framework to successfully understand identified barriers, benefits, and cues to action. Lastly, the inclusion of Spanish speaking participants is another study strength.</p>
<p>The study has several limitations. First, there is a possibility that participants felt compelled to offer socially desirable responses. To reduce response bias, the first author assured participants that there were no right or wrong answers before starting the interview. Second, we employed a non-probability sampling method, which limits the generalizability of the findings. Lastly, all participants were currently smoking and had medical insurance. Future studies should purposely include Latinos who have quit smoking and have no medical insurance to understand their perspectives on lung cancer screening.</p>
</sec>
</sec>
<sec id="s5" sec-type="conclusions">
<label>5</label>
<title>Conclusion</title>
<p>Most Latinos who were eligible for lung cancer screening were unaware of it, and when informed, they reported multiple perceived benefits, barriers, and cues to action. These factors provide concrete operational strategies to address lung cancer screening among Latinos.</p>
</sec>
<sec id="s6" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/supplementary material. Further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s7" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The studies involving humans were approved by University of Rochester Medical Center. The studies were conducted in accordance with the local legislation and institutional requirements. The ethics committee/institutional review board waived the requirement of written informed consent for participation from the participants or the participants&#x2019; legal guardians/next of kin because Verbal consent was obtained from the participants before enrollment in the study.</p>
</sec>
<sec id="s8" sec-type="author-contributions">
<title>Author contributions</title>
<p>EA-C: Formal analysis, Project administration, Writing &#x2013; original draft. KG: Formal analysis, Writing &#x2013; review &amp; editing. LS: Formal analysis, Writing &#x2013; review &amp; editing. EA: Data curation, Writing &#x2013; review &amp; editing. AC-I: Project administration, Writing &#x2013; review &amp; editing. ME: Writing &#x2013; review &amp; editing. MG: Writing &#x2013; review &amp; editing. FL: Writing &#x2013; review &amp; editing. RY-N: Writing &#x2013; review &amp; editing. KF: Writing &#x2013; review &amp; editing. MR: Conceptualization, Writing &#x2013; review &amp; editing. AC: Conceptualization, Writing &#x2013; review &amp; editing. FC-B: Conceptualization, Formal Analysis, Writing &#x2013; original draft.</p>
</sec>
</body>
<back>
<sec id="s9" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. Research reported in this publication was supported by the Prevent Cancer Foundation. EA-C was supported by the National Medical Fellowships. KG and LS were supported by the American Society of Clinical Oncology. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Prevent Cancer Foundation, the National Medical Fellowships, and the American Society of Clinical Oncology.</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>The authors are grateful to the individuals who participated in this study. Moreover, the authors thank to Christina Sisson and Erin Schmidt for their administrative support.</p>
</ack>
<sec id="s10" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s11" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sung</surname> <given-names>H</given-names>
</name>
<name>
<surname>Ferlay</surname> <given-names>J</given-names>
</name>
<name>
<surname>Siegel</surname> <given-names>RL</given-names>
</name>
<name>
<surname>Laversanne</surname> <given-names>M</given-names>
</name>
<name>
<surname>Soerjomataram</surname> <given-names>I</given-names>
</name>
<name>
<surname>Jemal</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Global Cancer Statistics 2020: GLOBOCAN Estimates of incidence and mortality worldwide for 36 cancers in 185 countries</article-title>. <source>CA Cancer J Clin</source>. (<year>2021</year>) <volume>71</volume>:<page-range>209&#x2013;49</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3322/caac.21660</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname> <given-names>KD</given-names>
</name>
<name>
<surname>Goding Sauer</surname> <given-names>A</given-names>
</name>
<name>
<surname>Ortiz</surname> <given-names>AP</given-names>
</name>
<name>
<surname>Fedewa</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Pinheiro</surname> <given-names>PS</given-names>
</name>
<name>
<surname>Tortolero-Luna</surname> <given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>Cancer statistics for hispanics/latinos, 2018</article-title>. <source>CA Cancer J Clin</source>. (<year>2018</year>) <volume>68</volume>:<page-range>425&#x2013;45</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3322/caac.21494</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="web">
<article-title>U.S. Census Bureau 2010 Race and ethnicity</article-title> . Available online at: <uri xlink:href="https://www.census.gov/quickfacts/fact/table/US/PST045219">https://www.census.gov/quickfacts/fact/table/US/PST045219</uri>.</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="web">
<person-group person-group-type="author">
<name>
<surname>Patten</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>The nation&#x2019;s Latino population is defined by its youth</article-title> . <publisher-name>Pew Research Center</publisher-name>. Available online at: <uri xlink:href="https://www.pewresearch.org/hispanic/2016/04/20/the-nations-latino-population-is-defined-by-its-youth/#:~:text=in%20the%20U.S.-,Nearly%20half%20of%20U.S.%2Dborn%20Latinos%20are%20younger%20than%2018,Latinos%20are%20younger%20than%2018">https://www.pewresearch.org/hispanic/2016/04/20/the-nations-latino-population-is-defined-by-its-youth/#:~:text=in%20the%20U.S.-,Nearly%20half%20of%20U.S.%2Dborn%20Latinos%20are%20younger%20than%2018,Latinos%20are%20younger%20than%2018</uri> (Accessed <access-date>12-28-2023</access-date>).</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Olazagasti</surname> <given-names>C</given-names>
</name>
<name>
<surname>Seetharamu</surname> <given-names>N</given-names>
</name>
</person-group>. <article-title>Disparities in lung cancer screening rates among the Hispanic/LatinX population</article-title>. <source>Lung Cancer Manag</source>. (<year>2021</year>) <volume>10</volume>:<fpage>LMT51</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.2217/lmt-2021-0004</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pinheiro</surname> <given-names>PS</given-names>
</name>
<name>
<surname>Callahan</surname> <given-names>KE</given-names>
</name>
<name>
<surname>Siegel</surname> <given-names>RL</given-names>
</name>
<name>
<surname>Jin</surname> <given-names>H</given-names>
</name>
<name>
<surname>Morris</surname> <given-names>CR</given-names>
</name>
<name>
<surname>Trapido</surname> <given-names>EJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Cancer mortality in Hispanic ethnic groups</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source>. (<year>2017</year>) <volume>26</volume>:<page-range>376&#x2013;82</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1158/1055-9965.EPI-16-0684</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaplan</surname> <given-names>RC</given-names>
</name>
<name>
<surname>Bangdiwala</surname> <given-names>SI</given-names>
</name>
<name>
<surname>Barnhart</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Casta&#xf1;eda</surname> <given-names>SF</given-names>
</name>
<name>
<surname>Gellman</surname> <given-names>MD</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>DJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Smoking among U.S. Hispanic/Latino adults: The Hispanic community health study/study of Latinos</article-title>. <source>Am J Prev Med</source>. (<year>2014</year>) <volume>46</volume>:<fpage>496</fpage>&#x2013;<lpage>506</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.amepre.2014.01.014</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<collab>National Lung Screening Trial Research Team</collab>
<name>
<surname>Aberle</surname> <given-names>DR</given-names>
</name>
<name>
<surname>Adams</surname> <given-names>AM</given-names>
</name>
<name>
<surname>Berg</surname> <given-names>CD</given-names>
</name>
<name>
<surname>Black</surname> <given-names>WC</given-names>
</name>
<name>
<surname>Clapp</surname> <given-names>JD</given-names>
</name>
<etal/>
</person-group>. <article-title>Reduced lung cancer mortality with low-dose computed tomographic screening</article-title>. <source>N Engl J Med</source>. (<year>2011</year>) <volume>365</volume>:<fpage>395</fpage>&#x2013;<lpage>409</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1056/NEJMoa1102873</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Koning</surname> <given-names>HJ</given-names>
</name>
<name>
<surname>van der Aalst</surname> <given-names>CM</given-names>
</name>
<name>
<surname>de Jong</surname> <given-names>PA</given-names>
</name>
<name>
<surname>Scholten</surname> <given-names>ET</given-names>
</name>
<name>
<surname>Nackaerts</surname> <given-names>K</given-names>
</name>
<name>
<surname>Heuvelmans</surname> <given-names>MA</given-names>
</name>
<etal/>
</person-group>. <article-title>Reduced lung-cancer mortality with volume CT screening in a randomized trial</article-title>. <source>N Engl J Med</source>. (<year>2020</year>) <volume>382</volume>:<page-range>503&#x2013;13</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1056/NEJMoa1911793</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="web">
<person-group person-group-type="author">
<collab>U.S. Preventive Services Task Force</collab>
</person-group>. <article-title>Lung cancer: Screening</article-title> . Available online at: <uri xlink:href="https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/lung-cancer-screening">https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/lung-cancer-screening</uri> (Accessed <access-date>12-28-2023</access-date>).</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wender</surname> <given-names>R</given-names>
</name>
<name>
<surname>Fontham</surname> <given-names>ET</given-names>
</name>
<name>
<surname>Barrera</surname> <given-names>E</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Colditz</surname> <given-names>GA</given-names>
</name>
<name>
<surname>Church</surname> <given-names>TR</given-names>
</name>
<name>
<surname>Ettinger</surname> <given-names>DS</given-names>
</name>
<etal/>
</person-group>. <article-title>American Cancer Society lung cancer screening guidelines</article-title>. <source>CA Cancer J Clin</source>. (<year>2013</year>) <volume>63</volume>:<page-range>107&#x2013;17</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3322/caac.21172</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fedewa</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Kazerooni</surname> <given-names>EA</given-names>
</name>
<name>
<surname>Studts</surname> <given-names>JL</given-names>
</name>
<name>
<surname>Smith</surname> <given-names>RA</given-names>
</name>
<name>
<surname>Bandi</surname> <given-names>P</given-names>
</name>
<name>
<surname>Sauer</surname> <given-names>AG</given-names>
</name>
<etal/>
</person-group>. <article-title>State variation in low-dose computed tomography scanning for lung cancer screening in the United States</article-title>. <source>J Natl Cancer Inst</source>. (<year>2021</year>) <volume>113</volume>:<page-range>1044&#x2013;52</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/jnci/djaa170</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jemal</surname> <given-names>A</given-names>
</name>
<name>
<surname>Fedewa</surname> <given-names>SA</given-names>
</name>
</person-group>. <article-title>Lung cancer screening with low-dose computed tomography in the United States-2010 to 2015</article-title>. <source>JAMA Oncol</source>. (<year>2017</year>) <volume>3</volume>:<page-range>1278&#x2013;81</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1001/jamaoncol.2016.6416</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Williams</surname> <given-names>RM</given-names>
</name>
<name>
<surname>Li</surname> <given-names>T</given-names>
</name>
<name>
<surname>Luta</surname> <given-names>G</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>MQ</given-names>
</name>
<name>
<surname>Adams-Campbell</surname> <given-names>L</given-names>
</name>
<name>
<surname>Meza</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Lung cancer screening use and implications of varying eligibility criteria by race and ethnicity: 2019 Behavioral Risk Factor Surveillance System data</article-title>. <source>Cancer</source>. (<year>2022</year>) <volume>128</volume>:<page-range>1812&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/cncr.34098</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="web">
<person-group person-group-type="author">
<collab>Healthy People 2030</collab>
</person-group>. <article-title>Cancer</article-title> . Available online at: <uri xlink:href="https://health.gov/healthypeople/objectives-and-data/browse-objectives/cancer">https://health.gov/healthypeople/objectives-and-data/browse-objectives/cancer</uri> (Accessed <access-date>12-28-2023</access-date>).</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zahnd</surname> <given-names>WE</given-names>
</name>
<name>
<surname>Eberth</surname> <given-names>JM</given-names>
</name>
</person-group>. <article-title>Lung cancer screening utilization: A behavioral risk factor surveillance system analysis</article-title>. <source>Am J Prev Med</source>. (<year>2019</year>) <volume>57</volume>:<page-range>250&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.amepre.2019.03.015</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okereke</surname> <given-names>IC</given-names>
</name>
<name>
<surname>Nishi</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>J</given-names>
</name>
<name>
<surname>Goodwin</surname> <given-names>JS</given-names>
</name>
</person-group>. <article-title>Trends in lung cancer screening in the United States, 2016&#x2013;2017</article-title>. <source>J Thorac Dis</source>. (<year>2019</year>) <volume>11</volume>:<page-range>873&#x2013;81</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.21037/jtd</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carter-Harris</surname> <given-names>L</given-names>
</name>
<name>
<surname>Slaven</surname> <given-names>JE</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Monahan</surname> <given-names>PO</given-names>
</name>
<name>
<surname>Shedd-Steele</surname> <given-names>R</given-names>
</name>
<name>
<surname>Hanna</surname> <given-names>N</given-names>
</name>
<name>
<surname>Rawl</surname> <given-names>SM</given-names>
</name>
</person-group>. <article-title>Understanding lung cancer screening behavior: Racial, gender, and geographic differences among Indiana long-term smokers</article-title>. <source>Prev Med Rep</source>. (<year>2018</year>) <volume>10</volume>:<fpage>49</fpage>&#x2013;<lpage>54</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.pmedr.2018.01.018</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Steiling</surname> <given-names>K</given-names>
</name>
<name>
<surname>Loui</surname> <given-names>T</given-names>
</name>
<name>
<surname>Asokan</surname> <given-names>S</given-names>
</name>
<name>
<surname>Nims</surname> <given-names>S</given-names>
</name>
<name>
<surname>Moreira</surname> <given-names>P</given-names>
</name>
<name>
<surname>Rebello</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Age, race, and income are associated with lower screening rates at a safety net hospital</article-title>. <source>Ann Thorac Surg</source>. (<year>2020</year>) <volume>109</volume>:<page-range>1544&#x2013;50</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.athoracsur.2019.11.052</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rivera</surname> <given-names>MP</given-names>
</name>
<name>
<surname>Gudina</surname> <given-names>AT</given-names>
</name>
<name>
<surname>Cartujano-Barrera</surname> <given-names>F</given-names>
</name>
<name>
<surname>Cupertino</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>Disparities across the continuum of lung cancer care</article-title>. <source>Clin Chest Med</source>. (<year>2023</year>) <volume>44</volume>:<page-range>531&#x2013;42</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ccm.2023.03.009</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Flores</surname> <given-names>EJ</given-names>
</name>
<name>
<surname>Irwin</surname> <given-names>KE</given-names>
</name>
<name>
<surname>Park</surname> <given-names>ER</given-names>
</name>
<name>
<surname>Carlos</surname> <given-names>RC</given-names>
</name>
</person-group>. <article-title>Increasing lung screening in the Latino community</article-title>. <source>J Am Coll Radiol</source>. (<year>2021</year>) <volume>18</volume>:<page-range>633&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jacr.2021.03.007</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Merriam</surname> <given-names>SB</given-names>
</name>
<name>
<surname>Johnson-Bailey</surname> <given-names>J</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>MY</given-names>
</name>
<name>
<surname>Kee</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Ntseane</surname> <given-names>G</given-names>
</name>
<name>
<surname>Muhamad</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Power and positionality: Negotiating insider/outsider status within and across cultures</article-title>. <source>Int J Lifelong Educ</source>. (<year>2001</year>) <volume>20</volume>:<page-range>405&#x2013;16</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/02601370110059537</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hern&#xe1;ndez-Torres</surname> <given-names>R</given-names>
</name>
<name>
<surname>Alaniz-Cantu</surname> <given-names>E</given-names>
</name>
<name>
<surname>Bautista Rojas</surname> <given-names>MV</given-names>
</name>
<name>
<surname>Lara</surname> <given-names>D</given-names>
</name>
<name>
<surname>Merritt</surname> <given-names>S</given-names>
</name>
<name>
<surname>DeJesus</surname> <given-names>E</given-names>
</name>
<etal/>
</person-group>. <article-title>Understanding the perspectives of Latino adults who smoke on physical activity: A qualitative study</article-title>. <source>Int J Environ Res Public Health</source>. (<year>2023</year>) <volume>20</volume>:<fpage>3128</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijerph20043128</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cartujano-Barrera</surname> <given-names>F</given-names>
</name>
<name>
<surname>Lee D&#x2019;Abundo</surname> <given-names>M</given-names>
</name>
<name>
<surname>Arana-Chicas</surname> <given-names>E</given-names>
</name>
<name>
<surname>Chock</surname> <given-names>S</given-names>
</name>
<name>
<surname>Valera</surname> <given-names>P</given-names>
</name>
<name>
<surname>Kamen</surname> <given-names>CS</given-names>
</name>
<etal/>
</person-group>. <article-title>Barriers and facilitators of smoking cessation among Latinos living with HIV: Perspectives from key leaders of community-based organizations and clinics</article-title>. <source>Int J Environ Res Public Health</source>. (<year>2021</year>) <volume>18</volume>:<fpage>3437</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijerph18073437</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cartujano-Barrera</surname> <given-names>F</given-names>
</name>
<name>
<surname>Arana-Chicas</surname> <given-names>E</given-names>
</name>
<name>
<surname>Catley</surname> <given-names>D</given-names>
</name>
<name>
<surname>Cox</surname> <given-names>LS</given-names>
</name>
<name>
<surname>Diaz</surname> <given-names>FJ</given-names>
</name>
<name>
<surname>Ellerbeck</surname> <given-names>EF</given-names>
</name>
<etal/>
</person-group>. <article-title>Dec&#xed;detexto: Mobile cessation support for Latino smokers. Study protocol for a randomized clinical trial</article-title>. <source>Contemp Clin Trials</source>. (<year>2020</year>) <volume>99</volume>:<fpage>106188</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cct.2020.106188</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cartujano-Barrera</surname> <given-names>F</given-names>
</name>
<name>
<surname>Sanderson Cox</surname> <given-names>L</given-names>
</name>
<name>
<surname>Arana-Chicas</surname> <given-names>E</given-names>
</name>
<name>
<surname>Ram&#xed;rez</surname> <given-names>M</given-names>
</name>
<name>
<surname>Perales-Puchalt</surname> <given-names>J</given-names>
</name>
<name>
<surname>Valera</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>Feasibility and acceptability of a culturally- and linguistically-adapted smoking cessation text messaging intervention for Latino smokers</article-title>. <source>Front Public Health</source>. (<year>2020</year>) <volume>8</volume>:<elocation-id>269</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fpubh.2020.00269</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cartujano-Barrera</surname> <given-names>F</given-names>
</name>
<name>
<surname>Arana-Chicas</surname> <given-names>E</given-names>
</name>
<name>
<surname>Ram&#xed;rez-Mantilla</surname> <given-names>M</given-names>
</name>
<name>
<surname>Perales</surname> <given-names>J</given-names>
</name>
<name>
<surname>Cox</surname> <given-names>LS</given-names>
</name>
<name>
<surname>Ellerbeck</surname> <given-names>EF</given-names>
</name>
<etal/>
</person-group>. <article-title>&#x201c;Every day I think about your messages&#x201d;: Assessing text messaging engagement among Latino smokers in a mobile cessation program</article-title>. <source>Patient Prefer Adherence</source>. (<year>2019</year>) <volume>13</volume>:<page-range>1213&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2147/PPA</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cartujano-Barrera</surname> <given-names>F</given-names>
</name>
<name>
<surname>Perales</surname> <given-names>J</given-names>
</name>
<name>
<surname>Arana</surname> <given-names>E</given-names>
</name>
<name>
<surname>Cox</surname> <given-names>LS</given-names>
</name>
<name>
<surname>Yeh</surname> <given-names>HW</given-names>
</name>
<name>
<surname>Ellerbeck</surname> <given-names>EF</given-names>
</name>
<etal/>
</person-group>. <article-title>Increasing access to smoking cessation treatment among Latino smokers using case management</article-title>. <source>J Smok Cessat</source>. (<year>2019</year>) <volume>14</volume>:<page-range>168&#x2013;75</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1017/jsc.2019.1</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rosenstock</surname> <given-names>IM</given-names>
</name>
<name>
<surname>Strecher</surname> <given-names>VJ</given-names>
</name>
<name>
<surname>Becker</surname> <given-names>MH</given-names>
</name>
</person-group>. <article-title>Social learning theory and the Health Belief Model</article-title>. <source>Health Educ Q</source>. (<year>1988</year>) <volume>15</volume>(<issue>2</issue>):<page-range>175&#x2013;83</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/109019818801500203</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lei</surname> <given-names>F</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>WT</given-names>
</name>
<name>
<surname>Brecht</surname> <given-names>ML</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>ZF</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>Health beliefs toward lung cancer screening among Chinese American high-risk smokers: Interviews based on Health Belief Model</article-title>. <source>Int J Nurs Sci</source>. (<year>2022</year>) <volume>9</volume>:<page-range>378&#x2013;88</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ijnss.2022.06.005</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pan</surname> <given-names>Y</given-names>
</name>
<name>
<surname>de la Puente</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Census Bureau guideline for the translation of data collection instruments and supporting materials: Documentation on how the guideline was developed</article-title>. <source>Surv Methodol</source>. (<year>2005</year>) <volume>6</volume>:<fpage>1</fpage>&#x2013;<lpage>38</lpage>.</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Boyatzis</surname> <given-names>RE</given-names>
</name>
</person-group>. <source>Transforming qualitative information: Thematic analysis</source>. <publisher-loc>Thousand Oaks, CA, USA</publisher-loc>: <publisher-name>Sage Publications</publisher-name> (<year>1998</year>).</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ando</surname> <given-names>HR</given-names>
</name>
<name>
<surname>Cousins</surname> <given-names>R</given-names>
</name>
<name>
<surname>Young</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Achieving saturation in thematic analysis: Development and refinement of a codebook</article-title>. <source>Compr Psychol</source>. (<year>2014</year>) <volume>3</volume>:<page-range>2165&#x2013;228</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2466/03.CP.3.4</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malterud</surname> <given-names>K</given-names>
</name>
<name>
<surname>Siersma</surname> <given-names>VD</given-names>
</name>
<name>
<surname>Guassora</surname> <given-names>AD</given-names>
</name>
</person-group>. <article-title>Sample size in qualitative interview studies: Guided by information power</article-title>. <source>Qual Health Res</source>. (<year>2016</year>) <volume>26</volume>:<page-range>1753&#x2013;60</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/1049732315617444</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hennink</surname> <given-names>M</given-names>
</name>
<name>
<surname>Kaiser</surname> <given-names>BN</given-names>
</name>
</person-group>. <article-title>Sample sizes for saturation in qualitative research: A systematic review of empirical tests</article-title>. <source>Soc Sci Med</source>. (<year>2022</year>) <volume>292</volume>:<fpage>114523</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.socscimed.2021.114523</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Percac-Lima</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ashburner</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Atlas</surname> <given-names>SJ</given-names>
</name>
<name>
<surname>Rigotti</surname> <given-names>NA</given-names>
</name>
<name>
<surname>Flores</surname> <given-names>EJ</given-names>
</name>
<name>
<surname>Kuchukhidze</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Barriers to and interest in lung cancer screening among Latino and non-Latino current and former smokers</article-title>. <source>J Immigr Minor Health</source>. (<year>2019</year>) <volume>21</volume>:<page-range>1313&#x2013;24</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10903-019-00860-2</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodr&#xed;guez-Rabassa</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Simmons</surname> <given-names>VN</given-names>
</name>
<name>
<surname>Vega</surname> <given-names>A</given-names>
</name>
<name>
<surname>Moreno</surname> <given-names>D</given-names>
</name>
<name>
<surname>Irizarry-Ramos</surname> <given-names>J</given-names>
</name>
<name>
<surname>Quinn</surname> <given-names>GP</given-names>
</name>
</person-group>. <article-title>Perceptions of and barriers to lung cancer screening among physicians in Puerto Rico: A qualitative study</article-title>. <source>J Health Care Poor Underserved</source>. (<year>2020</year>) <volume>31</volume>:<page-range>973&#x2013;91</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1353/hpu.2020.0072</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alcaraz</surname> <given-names>KI</given-names>
</name>
<name>
<surname>Wiedt</surname> <given-names>TL</given-names>
</name>
<name>
<surname>Daniels</surname> <given-names>EC</given-names>
</name>
<name>
<surname>Yabroff</surname> <given-names>KR</given-names>
</name>
<name>
<surname>Guerra</surname> <given-names>CE</given-names>
</name>
<name>
<surname>Wender</surname> <given-names>RC</given-names>
</name>
</person-group>. <article-title>Understanding and addressing social determinants to advance cancer health equity in the United States: A blueprint for practice, research, and policy</article-title>. <source>CA Cancer J Clin</source>. (<year>2020</year>) <volume>70</volume>:<fpage>31</fpage>&#x2013;<lpage>46</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3322/caac.21586</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Korn</surname> <given-names>AR</given-names>
</name>
<name>
<surname>Walsh-Bailey</surname> <given-names>C</given-names>
</name>
<name>
<surname>Correa-Mendez</surname> <given-names>M</given-names>
</name>
<name>
<surname>DelNero</surname> <given-names>P</given-names>
</name>
<name>
<surname>Pilar</surname> <given-names>M</given-names>
</name>
<name>
<surname>Sandler</surname> <given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>Social determinants of health and US cancer screening interventions: A systematic review</article-title>. <source>CA Cancer J Clin</source>. (<year>2023</year>) <volume>73</volume>:<page-range>461&#x2013;79</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3322/caac.21801</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Braveman</surname> <given-names>P</given-names>
</name>
<name>
<surname>Gruskin</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Defining equity in health</article-title>. <source>J Epidemiol Community Health</source>. (<year>2003</year>) <volume>57</volume>:<page-range>254&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1136/jech.57.4.254</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McMahon</surname> <given-names>PM</given-names>
</name>
<name>
<surname>Kong</surname> <given-names>CY</given-names>
</name>
<name>
<surname>Bouzan</surname> <given-names>C</given-names>
</name>
<name>
<surname>Weinstein</surname> <given-names>MC</given-names>
</name>
<name>
<surname>Cipriano</surname> <given-names>LE</given-names>
</name>
<name>
<surname>Tramontano</surname> <given-names>AC</given-names>
</name>
<etal/>
</person-group>. <article-title>Cost-effectiveness of computed tomography screening for lung cancer in the United States</article-title>. <source>J Thorac Oncol</source>. (<year>2011</year>) <volume>6</volume>:<page-range>1841&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/JTO.0b013e31822e59b3</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Villanti</surname> <given-names>AC</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Abrams</surname> <given-names>DB</given-names>
</name>
<name>
<surname>Pyenson</surname> <given-names>BS</given-names>
</name>
</person-group>. <article-title>A cost-utility analysis of lung cancer screening and the additional benefits of incorporating smoking cessation interventions</article-title>. <source>PloS One</source>. (<year>2013</year>) <volume>8</volume>:<fpage>e71379</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0071379</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taylor</surname> <given-names>KL</given-names>
</name>
<name>
<surname>Williams</surname> <given-names>RM</given-names>
</name>
<name>
<surname>Li</surname> <given-names>T</given-names>
</name>
<name>
<surname>Luta</surname> <given-names>G</given-names>
</name>
<name>
<surname>Smith</surname> <given-names>L</given-names>
</name>
<name>
<surname>Davis</surname> <given-names>KM</given-names>
</name>
<etal/>
</person-group>. <article-title>Georgetown Lung Screening, Tobacco, and Health Trial. A randomized trial of telephone-based smoking cessation treatment in the lung cancer screening setting</article-title>. <source>J Natl Cancer Inst</source>. (<year>2022</year>) <volume>114</volume>:<page-range>1410&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/jnci/djac127</pub-id>
</citation>
</ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cao</surname> <given-names>P</given-names>
</name>
<name>
<surname>Smith</surname> <given-names>L</given-names>
</name>
<name>
<surname>Mandelblatt</surname> <given-names>JS</given-names>
</name>
<name>
<surname>Jeon</surname> <given-names>J</given-names>
</name>
<name>
<surname>Taylor</surname> <given-names>KL</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Cost-effectiveness of a telephone-based smoking cessation randomized trial in the lung cancer screening setting</article-title>. <source>JNCI Cancer Spectr</source>. (<year>2022</year>) <volume>6</volume>:<fpage>pkac048</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/jncics/pkac048</pub-id>
</citation>
</ref>
<ref id="B45">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>P&#xe9;rez-Stable</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>Issues in Latino health care</article-title>. <source>West J Med</source>. (<year>1987</year>) <volume>146</volume>:<page-range>213&#x2013;8</page-range>.</citation>
</ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Flores</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Culture and the patient-physician relationship: Achieving cultural competency in health care</article-title>. <source>J Pediatr</source>. (<year>2000</year>) <volume>136</volume>:<fpage>14</fpage>&#x2013;<lpage>23</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0022-3476(00)90043-X</pub-id>
</citation>
</ref>
<ref id="B47">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bullock</surname> <given-names>K</given-names>
</name>
<name>
<surname>McGraw</surname> <given-names>SA</given-names>
</name>
</person-group>. <article-title>A community capacity-enhancement approach to breast and cervical cancer screening among older women of color</article-title>. <source>Health Soc Work</source>. (<year>2006</year>) <volume>31</volume>:<page-range>16 &#x2013;25</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/hsw/31.1.16</pub-id>
</citation>
</ref>
<ref id="B48">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tejeda</surname> <given-names>S</given-names>
</name>
<name>
<surname>Thompson</surname> <given-names>B</given-names>
</name>
<name>
<surname>Coronado</surname> <given-names>GD</given-names>
</name>
<name>
<surname>Martin</surname> <given-names>DP</given-names>
</name>
</person-group>. <article-title>Barriers and facilitators related to mammography use among lower educated Mexican women in the USA</article-title>. <source>Soc Sci Med</source>. (<year>2009</year>) <volume>68</volume>:<page-range>832&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.socscimed.2008.12.023</pub-id>
</citation>
</ref>
<ref id="B49">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dominic</surname> <given-names>OG</given-names>
</name>
<name>
<surname>Chinchilli</surname> <given-names>V</given-names>
</name>
<name>
<surname>Wasserman</surname> <given-names>E</given-names>
</name>
<name>
<surname>Curry</surname> <given-names>WJ</given-names>
</name>
<name>
<surname>Kambic</surname> <given-names>DM</given-names>
</name>
<name>
<surname>Caicedo</surname> <given-names>CH</given-names>
</name>
<etal/>
</person-group>. <article-title>Impact of social support on colorectal cancer screening among adult Hispanics/Latinos: A randomized community-based study in central Pennsylvania</article-title>. <source>Cancer Prev Res</source>. (<year>2020</year>) <volume>13</volume>:<page-range>531&#x2013;42</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1158/1940-6207.CAPR-19-0333</pub-id>
</citation>
</ref>
<ref id="B50">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ashida</surname> <given-names>S</given-names>
</name>
<name>
<surname>Wilkinson</surname> <given-names>AV</given-names>
</name>
<name>
<surname>Koehly</surname> <given-names>LM</given-names>
</name>
</person-group>. <article-title>Motivation for health screening: Evaluation of social influence among Mexican-American adults</article-title>. <source>Am J Prev Med</source>. (<year>2010</year>) <volume>38</volume>:<fpage>396</fpage>&#x2013;<lpage>402</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.amepre.2009.12.028</pub-id>
</citation>
</ref>
<ref id="B51">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Israel</surname> <given-names>BA</given-names>
</name>
<name>
<surname>Schulz</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Parker</surname> <given-names>EA</given-names>
</name>
<name>
<surname>Becker</surname> <given-names>AB</given-names>
</name>
</person-group>. <article-title>Review of community-based research: Assessing partnership approaches to improve public health</article-title>. <source>Annu Rev Public Health</source>. (<year>1998</year>) <volume>19</volume>:<fpage>173</fpage>&#x2013;<lpage>202</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev.publhealth.19.1.173</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>